Printer Friendly


Interleukin Genetics, Inc. introduces PerioPredict[TM], the company's new, next-generation version of the PST[R] genetic risk test for periodontal disease. Like the original PST[R] test, Perio-Predict[TM] measures variations in the genes for Interleukin-1 (IL-1), a key mediator of inflammation, and identifies individuals who are at an increased risk for more severe periodontal disease. The new and improved sample collection device now incorporates a simple, easy-to-use cheek swab. The new test also utilizes an expansion of previous genetic markers that now cover all major ethnic groups including Hispanic, African-American and Asian, in addition to Caucasian. Quick, easy and painless, the test is performed by dental hygienists or dentists in about a minute during a routine examination or prophylaxis. The sample is then sent to Interleukin Genetics, Inc., a CLIA-certified genetics laboratory, for analysis. Test results are returned to the dentist in about two weeks. For more information, visit

COPYRIGHT 2014 American Dental Hygienists' Association
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2014 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:product report
Date:Feb 1, 2014
Previous Article:The new upgraded Philips Sonicare AirFloss.
Next Article:GoodMouth.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters